| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/30/2006 | WO2006032631A1 Inhibitors of the interaction between mdm2 and p53 |
| 03/30/2006 | WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005072413A3 Heterocycle grafted monomers and related polymers and hybrid inorganic-organic polymer membranes |
| 03/30/2006 | WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/30/2006 | WO2004092346A3 Small molecule inhibition of a pdz-domain interaction |
| 03/30/2006 | US20060069256 Ophthalmic compositions for treating ocular hypertension |
| 03/30/2006 | US20060069143 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 03/30/2006 | US20060069135 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
| 03/30/2006 | US20060069130 Novel crystals |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069128 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/30/2006 | US20060069127 Such as R) N-{1-[1-(4-Ethoxy-phenyl)-4-phenyl-1H-imidazol-2-yl]-ethyl}-2-(4-fluoro-3-trifluoromethyl-phenyl)-N-pyridin-3-ylmethyl-acetamide, for therapy of inflammatory and immune disorders and disease such as multiple sclerosis, rheumatoid arthritis, psoriasis, and inflammatory bowel disease |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069123 Substituted dipiperidine CCR2 antagonists |
| 03/30/2006 | US20060069122 storage stability; autoimmune diseases |
| 03/30/2006 | US20060069110 Antiinflamamtory agents; cardiovascular disorders; brain disorders; antiarthritic agents; antidiabetic agents; antiallergens; leukemia; adult respirartory distress syndrome; Crohn's disease |
| 03/30/2006 | US20060069109 Therapeutic agents |
| 03/30/2006 | US20060069106 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 03/30/2006 | US20060069105 Protein tyrosine kinase inhibitors |
| 03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/30/2006 | US20060069090 Triazine compounds |
| 03/30/2006 | US20060069087 Histamine-3 receptor antagonists |
| 03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
| 03/30/2006 | US20060069034 Antipathogenic benzamide compounds |
| 03/30/2006 | DE102004047517A1 Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid Novel crystal form of (3-cyano-1H-indol-7-yl) - [4- (4-fluorophenethyl) piperazin-1-yl] -methanone, hydrochloride |
| 03/30/2006 | CA2582492A1 Novel pyrimidine derivatives and their use |
| 03/30/2006 | CA2581623A1 Novel pyridine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 03/30/2006 | CA2581454A1 Novel pyrimidine compounds, process for their preparation and compositions containing them |
| 03/30/2006 | CA2581338A1 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 03/30/2006 | CA2580855A1 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| 03/30/2006 | CA2580844A1 Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase |
| 03/30/2006 | CA2580610A1 Diaminotriazole compounds useful as protein kinase inhibitors |
| 03/30/2006 | CA2580198A1 Novel phthalazinone derivatives as aurora-a kinase inhibitors |
| 03/30/2006 | CA2577818A1 New heterocyclic amides |
| 03/29/2006 | EP1638963A1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 03/29/2006 | EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 03/29/2006 | EP1638955A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 03/29/2006 | EP1638954A1 Fused azoles such as 2,5-disubstituted benzimidazoles, benzoxazoles and benzothiazoles as kinase inhibitors |
| 03/29/2006 | EP1638953A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 03/29/2006 | EP1638944A1 Tachykinin receptor antagonists |
| 03/29/2006 | EP1638943A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 03/29/2006 | EP1638942A1 Cis-2,4,5-triaryl-imidazolines |
| 03/29/2006 | EP1638935A1 Nk1 antagonist |
| 03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 03/29/2006 | EP1638568A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 03/29/2006 | EP1461083B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 03/29/2006 | EP1102782B1 Structural analogs of amine bases and nucleosides |
| 03/29/2006 | EP0979823B1 Novel amide compounds and drugs containing the same |
| 03/29/2006 | CN1753996A The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 03/29/2006 | CN1753890A Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity |
| 03/29/2006 | CN1753882A Ethynyl derivatives serving as factor XA inhibitors |
| 03/29/2006 | CN1753877A Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 03/29/2006 | CN1753876A New pyridazin-3(2h)-one derivatives |
| 03/29/2006 | CN1753868A Novel compounds and compositions containing the same |
| 03/29/2006 | CN1753677A Ocular hypotensive agent |
| 03/29/2006 | CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/29/2006 | CN1247548C Cesium triazoleamide compounds and their preparation and use |
| 03/28/2006 | US7019148 Synthesis of irbesartan |
| 03/28/2006 | US7019144 E.g. 1-(4-methanesulfonylphenyl)-5-phenyl-3-trifluoromethyl-1H-1,2,4-triazole; side effect reduction; antipyretics; analgesics; non-steroidal antiinflamatory agents; cyclooxygenase 2 inhibitors; anticarcinogenic agents; Alzheimer's disease; antiulcer agents; gastrointestinal disorders |
| 03/28/2006 | US7019053 Stabilizer mixtures |
| 03/28/2006 | US7019021 such as 2-(6-bromo-3-dimethylamino-2-methylphenylimino)imidazolidine; stress |
| 03/28/2006 | US7019011 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019005 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors |
| 03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
| 03/28/2006 | US7018999 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound. |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
| 03/28/2006 | US7018570 produced by melt-mixing a benzotriazole and a resin stabilizer; has excellent compatibility with synthetic resins and provides a stabilized synthetic resin molding |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/28/2006 | CA2156121C Method of manufacturing the cycloheptimidazole derivatives |
| 03/23/2006 | WO2006031852A1 Vanilloid receptor ligands and their use in treatments |
| 03/23/2006 | WO2006031806A2 2-thiopyrimidinones as therapeutic agents |
| 03/23/2006 | WO2006030805A1 Triazole derivative or salt thereof |
| 03/23/2006 | WO2006029912A1 Indole derivatives as antiviral agents |
| 03/23/2006 | WO2006029867A1 5-heterocyclyl pyrimidines |
| 03/23/2006 | WO2006029829A1 Heteroaroyl-substituted serine amides utilized as herbicides |
| 03/23/2006 | WO2005082892A3 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063930 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/23/2006 | US20060063864 Diindole substituted squarylium compound; filters capable of selectively blocking light with wavelengths that degrade color purity |
| 03/23/2006 | US20060063822 inflammation; diabetes; vascular restenosis; hypertension; asthma; rheumatiod arthritis; osteoarthritis; cancer; and inflammatory bowel disease; thrombosis; atherosclerosis; |
| 03/23/2006 | US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren |
| 03/23/2006 | US20060063812 Indole derivatives |
| 03/23/2006 | US20060063811 Pyridinalkyl-aminoalkyl-ih-indole derivatives having an inhibitory action on 5-ht and serotonin reuptake as antidepressants and anxiolytics |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063807 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/23/2006 | US20060063803 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 03/23/2006 | US20060063796 Pyrazoles as inhibitors of tumor necrosis factor |
| 03/23/2006 | US20060063790 drugs such as 1,2,3,4-tetrahydro-2-[[2-(3-methyl-1-piperidinyl)-4-(1-phenylcyclopropyl)-5-pyrimidinyl]carbonyl]-isoquinoline and carriers administered as cognition activators |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063779 Pyridyl inhibitors of hedgehog signalling |
| 03/23/2006 | US20060063776 heterocyclic amines such as 1-(4-Chloro-phenyl)-cyclobutyl]-{3-[4-(2-methoxy-phenyl)-piperazin-1-ylmethyl]-piperidin-1-yl}-methanone; used as dopamine, serotonin or norepinephrine transporters; addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, Alzheimer's disease, obesity |